{"id":"https://openalex.org/W2018193151","doi":"https://doi.org/10.1254/fpj.87.537","title":"Pharmacological study of nicergoline. (III) Effects on cerebral and peripheral circulation in animals.","display_name":"Pharmacological study of nicergoline. (III) Effects on cerebral and peripheral circulation in animals.","publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W2018193151","doi":"https://doi.org/10.1254/fpj.87.537","mag":"2018193151","pmid":"https://pubmed.ncbi.nlm.nih.gov/3732963"},"language":"ja","primary_location":{"id":"doi:10.1254/fpj.87.537","doi":"https://doi.org/10.1254/fpj.87.537","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.87.537","pdf_url":"https://www.jstage.jst.go.jp/article/fpj1944/87/5/87_5_537/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/fpj1944/87/5/87_5_537/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111848551","display_name":"Keiichi SHINTOMI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keiichi SHINTOMI","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac(\u682a)\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac(\u682a)\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079281105","display_name":"Youri OGAWA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Youri OGAWA","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac(\u682a)\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac(\u682a)\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055615526","display_name":"Kenichi YOSHIMOTO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenichi YOSHIMOTO","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac(\u682a)\u5b89\u5168\u6027\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac(\u682a)\u5b89\u5168\u6027\u7814\u7a76\u6240","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007403283","display_name":"Hiroshi Narita","orcid":"https://orcid.org/0000-0003-4678-2645","observed_orcids":["https://orcid.org/0000-0003-4678-2645"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroshi NARITA","raw_affiliation_strings":["\u7530\u8fba\u88fd\u85ac(\u682a)\u751f\u7269\u7814\u7a76\u6240"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u7530\u8fba\u88fd\u85ac(\u682a)\u751f\u7269\u7814\u7a76\u6240","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3371,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.44484379,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"87","issue":"5","first_page":"537","last_page":"549"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.15410000085830688,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.09889999777078629,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicergoline","display_name":"nicergoline","score":1.0},{"id":"https://openalex.org/keywords/cerebral-circulation","display_name":"cerebral circulation","score":0.7429999709129333},{"id":"https://openalex.org/keywords/peripheral-circulation","display_name":"peripheral circulation","score":0.984000027179718},{"id":"https://openalex.org/keywords/regional-cerebral-blood-flow","display_name":"regional cerebral blood flow","score":0.9850000143051147},{"id":"https://openalex.org/keywords/intracranial-pressure","display_name":"intracranial pressure","score":0.9120000004768372},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.8370000123977661},{"id":"https://openalex.org/keywords/vasodilation","display_name":"vasodilation","score":0.8519999980926514},{"id":"https://openalex.org/keywords/alpha-adrenergic-blockade","display_name":"alpha-adrenergic blockade","score":0.9670000076293945},{"id":"https://openalex.org/keywords/dihydroergotoxine","display_name":"dihydroergotoxine","score":0.8519999980926514},{"id":"https://openalex.org/keywords/papaverine","display_name":"papaverine","score":1.0},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.44999998807907104},{"id":"https://openalex.org/keywords/epinephrine","display_name":"epinephrine","score":0.460999995470047},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cats","display_name":"cats","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C119671327","wikidata":"https://www.wikidata.org/wiki/Q886843","display_name":"Cerebral circulation","level":2,"score":0.6818846464157104},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.6688460111618042},{"id":"https://openalex.org/C11111821","wikidata":"https://www.wikidata.org/wiki/Q205880","display_name":"Circulation (fluid dynamics)","level":2,"score":0.5828076004981995},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46993809938430786},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3904447555541992},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3388999104499817},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3374584913253784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32973772287368774},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.32048994302749634},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.17720380425453186},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.11784759163856506},{"id":"https://openalex.org/C57879066","wikidata":"https://www.wikidata.org/wiki/Q41217","display_name":"Mechanics","level":1,"score":0.09912848472595215}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001775","descriptor_name":"Blood Circulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D002415","descriptor_name":"Cats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004087","descriptor_name":"Dihydroergotamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004837","descriptor_name":"Epinephrine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009530","descriptor_name":"Nicergoline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D010208","descriptor_name":"Papaverine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012039","descriptor_name":"Regional Blood Flow","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1254/fpj.87.537","doi":"https://doi.org/10.1254/fpj.87.537","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.87.537","pdf_url":"https://www.jstage.jst.go.jp/article/fpj1944/87/5/87_5_537/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},{"id":"pmid:3732963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3732963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1254/fpj.87.537","doi":"https://doi.org/10.1254/fpj.87.537","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.87.537","pdf_url":"https://www.jstage.jst.go.jp/article/fpj1944/87/5/87_5_537/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2018193151.pdf","grobid_xml":"https://content.openalex.org/works/W2018193151.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2091061931","https://openalex.org/W255976257","https://openalex.org/W1964520047","https://openalex.org/W2410077145","https://openalex.org/W2060114762","https://openalex.org/W2120289576","https://openalex.org/W2247650488","https://openalex.org/W2056448354","https://openalex.org/W2468679995","https://openalex.org/W2415040532"],"abstract_inverted_index":{"Effects":[0],"of":[1,13,27,58,70,113,135,163,178,188,193,211,235],"nicergoline":[2,28,71,164,212,236],"on":[3,63],"the":[4,43,56,209,229,248],"cerebral":[5,90,99,230],"and":[6,16,50,84,106,121,146,148,175,199,231,244],"peripheral":[7,232],"circulation":[8],"were":[9],"compared":[10],"with":[11,202],"those":[12],"dihydroergotoxine":[14],"(DHE)":[15],"papaverine":[17],"(PAP)":[18],"in":[19,39,80,89,119,126,142,158,173,206,221,223,247],"anesthetized":[20],"and/or":[21],"immobilized":[22],"cats.":[23],"The":[24,67,110,132,160,186],"i.a.":[25],"injection":[26,57,69,112,134],"(0.032":[29],"approximately":[30,73,166,214],"32":[31],"micrograms/kg),":[32],"similarly":[33],"to":[34,181,196,240],"PAP,":[35],"caused":[36,76,149,169],"dose-dependent":[37,78,171,219],"increases":[38,141],"intramaxillary":[40],"artery":[41,52],"(as":[42],"human":[44],"intracarotid":[45],"artery)":[46],"blood":[47,53,65,81,100],"flow":[48,101],"(IMBF)":[49],"femoral":[51],"flow,":[54],"but":[55,93],"DHE":[59,114,189],"had":[60],"no":[61],"effect":[62],"these":[64],"flows.":[66],"i.v.":[68,111,133],"(32":[72],"128":[74],"micrograms/kg)":[75],"a":[77,85,116,122,150,155,170,203,218],"fall":[79,118,152,172,205,220],"pressure":[82,104,179,194],"(BP)":[83],"transient":[86,151],"slight":[87,117,204],"decrease":[88,125],"vascular":[91],"resistance,":[92],"did":[94],"not":[95],"affect":[96],"IMBF,":[97,143],"regional":[98],"(r-CBF),":[102],"intracranial":[103],"(ICP)":[105],"heart":[107],"rate":[108],"(HR).":[109],"produced":[115,190],"BP":[120,174,222],"marked":[123,140,156,191],"long-lasting":[124],"HR,":[127],"without":[128],"affecting":[129],"other":[130],"parameters.":[131],"PAP":[136],"(4":[137],"mg/kg)":[138,168,216],"induced":[139,217],"r-CBF,":[144],"ICP":[145],"HR":[147],"followed":[153],"by":[154],"elevation":[157],"BP.":[159,207],"p.o.":[161],"administration":[162,187,210],"(0.06":[165],"4":[167],"selective":[176],"inhibition":[177,192],"response":[180],"adrenaline":[182,198],"(ID50:":[183],"0.25":[184],"mg/kg).":[185],"responses":[195],"both":[197],"noradrenaline,":[200],"accompanied":[201],"Furthermore,":[208],"(3":[213],"100":[215],"SHR.":[224],"These":[225],"results":[226],"suggest":[227],"that":[228],"circulatory":[233],"effects":[234],"may":[237],"be":[238],"due":[239],"direct":[241],"vasodilating":[242],"action":[243,246],"alpha-blocking":[245],"animals.":[249]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}